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The kidney has key roles in maintaining human health. There is an escalating medical crisis in nephrology as
growing numbers of patients suffer from kidney diseases that culminate in organ failure. While dialysis and
transplantation provide life-saving treatments, these therapies are rife with limitations and place significant burdens
on patients and healthcare systems. It has become imperative to find alternative ways to treat existing kidney
conditions and preemptive means to stave off renal dysfunction. The creation of innovative medical approaches
that utilize stem cells has received growing research attention. In this review, we discuss the regenerative and
maladaptive cellular responses that occur during acute and chronic kidney disease, the emerging evidence about
renal stem cells, and some of the issues that lie ahead in bridging the gap between basic stem cell biology and
regenerative medicine for the kidney.
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The kidney performs essential physiological jobs ranging
from metabolic waste excretion to homeostatic functions
like osmoregulation. Kidney diseases are currently a glo-
bal public health problem, with an incidence that has
reached epidemic proportions and continues to climb in
the U.S. and worldwide [1]. These trends correlate with
the global rise in the aged population and the increasing
prevalence of conditions that cause renal complications,
namely cardiovascular disease, hypertension and diabetes
[2]. Kidney diseases arise from congenital defects as well
as acquired conditions that result from acute kidney
injury (AKI) or chronic kidney disease (CKD) [3-7]. AKI
involves a rapid loss of kidney function from sudden
renal cell damage, which can be triggered by ischemia,
toxins, or sepsis [4-6]. CKD is typified by the progressive
loss of kidney function over time due to fibrosis and the
erosion of healthy tissue [7]. Kidney disease leads to
organ failure, known as end-stage renal disease (ESRD),
which requires renal replacement therapy with dialysis
or transplantation. Although renal failure can be managed
clinically, it has high mortality rates and necessitates in-
tensive, long-term care. This places a considerable burden* Correspondence: rwingert@nd.edu
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in any medium, provided the original work is pon patients and their families, and a tremendous socioeco-
nomic strain on healthcare systems [2].
The need for new methods to alleviate, cure, or pre-
vent renal disease has fueled great interest in the topic
of kidney stem cell biology. For over a decade now, the
use of stem cells for regenerative medicine has been
broadly heralded as the coming of a new age in healthcare
[8]. Unfortunately, the sheer magnitude of the excitement,
hope, and promise surrounding the notion of stem cell
therapies has been rivaled by the enormity of the chal-
lenges in making such approaches a reality. A major hur-
dle facing nephrology researchers is that the human
kidney has been classically defined as a non-proliferative
and non-regenerative organ. However, with the discovery
of adult stem cells in organs that were once thought to be
non-regenerative (like the brain), the cellular make-up of
the kidney has come to be reevaluated. There is emerging
evidence that human kidneys possess innate regenerative
abilities. For example, diabetic patients with CKD
exhibited reversion of fibrotic lesions in their kidneys ten
years after receiving a pancreas transplant [9,10]. Recent
research efforts have focused on better understanding
how the kidney can heal after injury, and determining if
the kidney contains stem cells that mediate tissue replace-
ment. Here we define the roles of stem cells in kidney de-
velopment, discuss how the adult kidney responds tois an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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istence of adult renal stem cells.
Review
Stem cells and their roles in development and
regeneration
Stem cells are unique cells that are able to replenish
themselves through self-renewal and can divide to pro-
duce differentiated (i.e. specialized) cell types (Figure 1)
[8]. Stem cells can self-renew through a symmetric cell
division, where both the newly produced offspring cells
maintain the characteristics of the parent stem cell.
Stem cells can also self-renew through asymmetric div-
ision, in which they produce a stem cell and another
offspring that has a different potency and lineage-
potential, such as a committed progenitor that transi-
ently amplifies to make several progeny (Figure 1).
Interestingly, stem cell division does not always have to
involve renewal, and can instead generate assorted com-
binations of offspring—like two progenitors or a pro-
genitor and a differentiated cell. The signals that trigger
stem cell division and progeny identity are influenced
by a complex interplay of intrinsic (cell autonomous)
factors as well as extrinsic factors such as those present
at the niche, which is the local microenvironment where
the stem cell resides.
Stem cells drive normal development and play many
roles in adult tissue regeneration [11]. Pluripotent stem
cells capable of giving rise to any cell lineage can be
isolated from early stage mammalian embryos. These
embryonic stem (ES) cells maintain pluripotency when
cultured in the right conditions [12]. As developmentFigure 1 The definition of a stem cell. (Top) Stem cells are characterized
offspring upon division. Stem cell progeny can include progenitor cells tha
immature precursors that precede the differentiated state. (Below) There is
move from a state of ‘stemness’ to that of terminal differentiation.progresses, lineage-restricted stem cells produce the tis-
sues and organs of the body. Development does not ne-
cessarily exhaust stem cell pools, and often leads to the
formation of tissue-specific or so-called adult stem cells
that are maintained throughout life. Adult stem cells
typically show more restricted potency (e.g. they are
multi-, bi, or unipotent), and have been discovered in
diverse creatures from simple metazoans like flies to
mammals like mice and humans [13]. In fact, adult stem
cells have been reported in a substantial list of human
tissues and organs. Adult stem cells can act to replace
cells that have a naturally limited lifespan, thus serving
to maintain the integrity of the soma. Further, many
adult stem cells can respond dynamically to injury and
fuel substantial regeneration of damaged tissues. For
these reasons, adult stem cells are thought to have pro-
found impacts on the etiology of disease, malignancy,
and aging [14,15]. Research efforts to identify regenera-
tive therapeutics have encompassed the study of ES cells,
adult stem cells, and the pursuit of reprogramming
methods to manipulate differentiated cells and obtain in-
duced pluripotent stem (iPS) cells that have broad
lineage potential similar to the ES cell [12].
Renal complexity: the kidney arises from stem cells
during development that produce diverse differentiated
cell types
The kidney develops from several stem cell pools during
organogenesis. As in other mammals, the human kidney
derives from intermediate mesoderm (IM) and proceeds
through three progressive phases, each marked by the
formation of a more advanced kidney: the pronephros,by having the dual capacity to self-renew and produce differentiated
t have substantial potency to proliferate and produce one or more
a continuum of potency that becomes progressively restricted as cells
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mesonephros, which only functions a short time during
embryonic development, and the metanephros, which
becomes the definitive form of the adult kidney [16].
The basic structural unit of each kidney form is the
nephron, an epithelial tube that accomplishes waste ex-
cretion. Nephrons have three major parts: (1) a glomeru-
lus that filters the blood, (2) a tubule that modifies the
filtrate to reabsorb and secrete solutes as the fluid passes
through proximal, intermediate, and distal segments,
and (3) a duct that carries the urine into a centralized
collecting system [17]. The pronephros and mesoneph-
ros are made from IM that develops into simple neph-
rons that are connected to a pair of nephric (Wolffian)
ducts, and these tissues degenerate in succession as the
metanephros forms. The metanephric kidney is pro-
duced when a localized region of the nephric duct forms
an outgrowth known as the ureteric bud (UB). The UB
invades the adjacent IM, which at this stage is termed
the metanephric mesenchyme (MM), and undergoes re-
iterative branching morphogenesis to create a complex
duct network. The MM aggregates and condenses to
form the cap mesenchyme (CM), a self-renewing stem
cell population that makes nephrons around the
branching UB [18-21]. Nephrogenesis proceeds when a
cluster of CM undergoes a mesenchymal to epithelial
transition (MET) into a renal vesicle. Each renal vesicle
will proliferate and undergo morphogenesis to make
one nephron. The loosely packed surrounding MMFigure 2 The human kidney is comprised of heterogenous cell types.
Nephrons are segmented epithelial subunits of the kidney. (Right nephron)
structure, and show varying lengths of intermediate segments throughout
system are also found. (B) Examples of differentiated nephron cell types, w
follows: ATL, ascending thin limb; G, glomerulus; CNT, connecting tubule; D
densa; PCT, proximal convoluted tubule; PST, proximal straight tubule; TAL,produces interstitial stroma. There is ongoing work to
characterize the UB and MM derivatives, and to profile
genes expressed by subsequent renal cell lineages, with
a large focus on the CM because of its self-renewal prop-
erty [18-21]. Although the CM exhibits self-renewal, the
CM is transient and the entire CM population is triggered
to undergo a final round of nephrogenesis at the end of
metanephros formation. There is no evidence that a CM
population is maintained to become an adult renal stem
cell population. It is currently unknown if self-renewal is a
short-lived property of CM renal stem cells and/or if de-
velopmental signaling induces all of the CM cells to be-
come renal vesicles that undergo nephrogenesis.
When metanephros development is complete, this kid-
ney has an elaborate, arborized architecture and diverse
cellular makeup due to the combined contributions of
CM, MM and UB progenitors. For example, over twenty
differentiated cell types have been annotated in the
human kidney [17] (Figure 2). Kidney composition is
conserved between mammals and even with lower verte-
brates like fish [17,22]. Nephrons alone contain more
than a dozen epithelial cell types with specific functions
(examples in Figure 2B)—which attests to the multi-
potency of CM stem cells during development [17]. The
absolute number of nephrons and their architecture
around the collecting system also renders complexity to
the metanephric kidney. For example, human nephron
endowment ranges from several hundred thousand to
over one million nephrons per kidney, being quite(A) The kidney is comprised of a cortex, medulla, and papilla regions.
Nephron segments are color-coded to depict the regionalized
the medulla and papilla region, where tracks of the collecting duct
hich display unique morphological features. Abbreviations are as
CT, distal convoluted tubule; DTL, descending thin limb; MD, macula
thick ascending limb.
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throughout the cortex, or outer zone of the kidney,
while their tubule loops and the collecting duct system
inhabit the inner zones of the medulla and papilla. Lo-
cated between nephrons and the collecting system is a
heterogeneous interstitial stroma inhabited by several
types of fibroblasts (Figure 2B), as well as immune cells
such as dendritic cells [17]. The kidney is also highly
vascularized, with extensive capillary networks of endo-
thelial cells and pericytes [17]. Finally, lymphatics are
present throughout the cortex, and the kidney is inner-
vated by fibers of the sympathetic and parasympathetic
nervous systems [17].
The identification of stem cells in these adult renal
structures has been riddled with controversy. Several lo-
cations in nephrons, the interstitium, and the collecting
system have been cited as housing cells with proliferative
potential. In some cases, there is evidence that prolifera-
tive capacity may exist in differentiated cells. Other
experimental data supports the notion of ‘stemness’ in
particular renal cells. In the following sections we dis-
cuss several relevant phenomena in kidney biology: first,
the adolescent growth of the kidney and nephron hyper-
trophy, followed by sections exploring the renal response
to damage and the evidence concerning the role(s) of
putative kidney stem cells and differentiated cells.
Renal cell dynamics in healthy kidneys: cell turnover and
hypertrophy
During juvenile life, the mammalian kidney undergoes
substantial normal growth even though organogenesis is
complete just before or immediately following birth.Figure 3 Kidney growth and compensatory hypertrophy occurs in he
and subsequently grow during juvenile/adolescent life, thus exhibiting hyp
net nephron functionality throughout the kidneys. (B) Following unilateral
in animal models, in which the kidney expands in size due to the hypertroFurther, kidneys have been documented to undergo a
dramatic compensatory response to the sudden removal
of renal tissue.
Nephrogenesis in humans is limited to early life
Nephron production, or nephrogenesis, is not the
stratagem for kidney maintenance in mammals. Rather,
nephrogenesis is limited to gestation or early post-natal
life. Human nephrogenesis ceases around week 36 of
gestation [25], while nephrogenesis subsides soon after
birth in rats and mice [26,27]. Although nephron en-
dowment is set early, mammalian kidneys grow remark-
ably in size and functionality during juvenile stages: as
body mass increases, overall kidney size and blood fil-
tration rates increase (Figure 3A) [28]. Nephrons grow
by hyperplasia and hypertrophy, leading to enlarge-
ments in glomerular size and tubule length that correl-
ate with the elevated capacity of the kidney to filter the
blood [28-30].
Cell turnover and hyperplasia during juvenile kidney
growth and adult homeostasis
Tissues throughout the mammalian body exhibit varying
rates of cellular turnover during adult life [11]. Epithelia
that are faced with high degrees of environmental stress
use virtually constant turnover rates of adult stem cells
and/or their transiently amplifying progeny as a strategy
to maintain tissue integrity, as seen in the skin [31] and
lining of the gastrointestinal tract [32] where millions of
cells are replaced daily. Kidney nephrons and collecting
duct epithelia are exposed to continual passage of filtrate,
and thousands of living cells from the healthy humanalthy kidneys. (A) Nephrons are produced during kidney ontogeny,
ertrophy with age in response to changing demands on renal use and
nephrectomy, there is a dramatic compensatory hypertrophy response
phy of individual nephrons.
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of exfoliated nephron tubular cells numbered ~78,000
cells per hour in men and ~68,000 cells per hour in
women [33]. Cells from this so-called urinary sediment
can be isolated and cultured, and include epithelial cells
shed from the kidney, ureters, bladder, and urethra
[33-36]. While the magnitude of renal cell turnover is
lower than other organs, homeostatic mechanism(s) are
still needed to maintain kidney functionality.
In adult kidneys, cell proliferation continues, albeit at
a reduced rate. Renal cell division has been documented
in several locales with pulse-chase labeling studies in
rodents. After providing a pulse of a nucleotide analog
(such as tritiated thymidine [thymidine-H3] or 5′-
bromo-2′deoxyuridine [BrdU]), its incorporation into
DNA enables the assessment of nuclear replication in
preparation for mitosis. Further, the duration of time
that the analog is maintained can be used to extrapolate
the cycling rate of the label retaining cells (LRCs). A
classic study using adult rats reported thymidine-H3
throughout nephron glomeruli, tubules, and the collecting
system after a short chase of 8, 24, or 72 hours [37]. More
recent BrdU pulse-chase studies in adult rats found LRCs
in glomeruli, tubules and collecting ducts after 7 days of
BrdU administration, and scattered LRCs in proximal and
distal nephron tubules after a 2 week chase [38,39]. Com-
parisons of proximal tubule proliferation in juvenile and
adult rats using BrdU pulse-chase and immunohistochem-
istry with mitosis markers showed that juveniles had div-
ision rates that were ~10 fold higher [40-42]. Healthy
human kidneys also have dividing cells in nephron tubules
based on staining for the cell division markers Ki67 and
proliferating cell nuclear antigen (PCNA) [43]. Interest-
ingly, both healthy rat and human kidneys have tubule
cells positive for cyclin D1—suggesting they are in the G1
phase of the cell cycle [42]. This finding is the basis of a
hypothesis that a pool of renal cells is poised for division
and may serve to bastion against intermittent single cell
loss or even more widespread, catastrophic insults [42].
Compensatory renal hypertrophy
Healthy mammalian kidneys can also undergo remark-
able adaptive changes in response to the elimination of
renal tissue. After unilateral nephrectomy, or the re-
moval of one kidney, the remaining kidney increases in
size through a process of compensatory renal hyper-
trophy (Figure 3B) [44,45]. The individual nephron cells
in the residual kidney enlarge. For example, nephron
tubular cell volume increases in proximal and distal
segments [44]. The nephrons also show functional adap-
tations, dramatically increasing their filtration and re-
absorption rates [44,45]. Thus, a kidney can respond to
shifts in physiological demands posed by marked, sud-
den organ loss by mechanisms that include cellularproliferation and/or hypertrophy. However, the ability of
the kidney to regenerate varies widely following exten-
sive direct injuries to cells within nephrons or the inter-
stitial environment, as discussed in the next several
sections that explore regeneration phenomena in the
nephron tubule and glomerulus.
Nephron tubule epithelium can be regenerated after AKI
Studies in animal models dating back several decades
have documented that AKI causes nephron tubule cell
death and local inflammation, followed by high cell pro-
liferation that restores tubule structure and function
(Figure 4A). Proximal tubule cells are particularly sensi-
tive to AKI from toxins, as they are intensely exposed to
blood-borne compounds that enter the tubule after fil-
tration, and from ischemic insults due to their high me-
tabolism. In fact, AKI research has largely focused on
the proximal S3 segment (see Figure 2A), which shows
the highest rate of death subsequent to these types of
acute insults. Seminal investigations using rat kidneys
documented a massive rise in the tubular mitotic index
and incorporation of thymidine-H3 several days after
mercuric chloride exposure [46]. Tubule repopulation
was also observed by histology after toxic exposure to
the antibiotic gentamicin [47]. Today, similar observations
have been made in AKI models of ischemia reperfusion
injury (IRI). Extensive proliferation in rat proximal tubules
after IRI was reported based on elevated numbers of
PCNA positive cells [48]. In BrdU pulse-chase studies
after IRI in adult rats, nephron tubules showed increased
numbers of scattered LRCs that were mostly PCNA posi-
tive [38]. Pathology studies of kidney samples from human
AKI patients have also documented prominent numbers
of intratubular PCNA positive cells [49], consistent with
the notion that a sizeable proliferation response can occur
in people after nephron damage. The explanation as to
why patients differ widely in their ability to regain renal
function after a bout of AKI is a resounding mystery, likely
complicated by an intricate host of genetic factors, the en-
vironment, and age. Nevertheless, these studies indicate
that mammalian nephron tubules (in principle) can harbor
cells with a robust proliferation capacity that are sufficient
in the right context to accomplish epithelial replacement.
An intratubular cell source fuels nephron tubule
epithelium regeneration after AKI
The origin of tubular dividing cells after AKI has been de-
bated between several scenarios (Figure 4B). In the first
model, surviving tubular cells dedifferentiate and undergo
an epithelial to mesenchymal transition (EMT) to become
a proliferating, migratory populace [4]. The tubular cells
proposed to undergo an EMT switch have included those
tubular cells detected in G1 in uninjured nephrons [42].
Following sufficient division, the mesenchymal cells are
Figure 4 Composition of nephron tubules in health and disease. (A) (Left) Healthy tubule with an intact epithelium. (Right) After injury,
tubules show the loss of epithelial cells into the luminal space, which denudes the basement membrane and is accompanied by local
inflammation. Mesenchymal stem cells (MSCs) provide restorative paracrine effects to damaged tubules. (B) Models of intratubular regeneration in
AKI include (left) the dedifferentiation of endogenous differentiated tubule epithelium and (right) the activation of renal stem/progenitor cells.
(C) (Left) In CKD, tubular damage is not restored and this is accompanied by a prolonged inflammatory response and the activation of
myofibroblasts. (Right) Over time, lesions from myofibroblasts replace once-healthy renal tissue and this fibrosis is associated with permanent
nephron erosion.
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This model was based on the observations that surviving
tubule cells had a flattened, squamous appearance [46,47],
expressed prototypical mesenchymal markers [48], and
lost polarity [50-52]. The idea of dedifferentiation was
based on the expression of developmental genes by these
squamous cells, including the transcription factor Paired
box 2 (Pax2) [53], the neural cell adhesion molecule
(NCAM) [54], and other nephrogenic genes [55]. Later,
a second model was proposed in which the kidney re-
ceived outside contributions from the bone marrow,
which is home to multipotent hematopoietic stem cellsand mesenchymal stem cells (MSCs) [56,57]. In this sce-
nario, bone marrow cells migrated to the damaged tu-
bules, where they engrafted and transdifferentiated to
make tubule epithelium [56,57].
Subsequent lineage tracing in murine IRI models has
provided compelling evidence that nephron epithelial re-
generation originates from an intratubular cell source
[58-60]. Chimeric mice in which the bone marrow was
labeled with either a transgenic marker (e.g. LacZ, eGFP)
or harbored a Y-chromosome showed no contribution of
cells with these labels to regenerating tubules [58]. Re-
ciprocally, studies that labeled tubular cells by transgenic
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only offspring with the marker and were not diluted with
unmarked cells [59,60]. While these studies ruled out
the scenario that bone marrow-derived cells directly
contribute to nephrons, bone marrow cell contributions
were confirmed in the renal interstitium [58,59]. There
is now evidence that the MSCs promote nephron recov-
ery after AKI through paracrine effects that prevent
apoptosis and enhance proliferation (Figure 4A) [61-65].
This suggests that there may be a therapeutic benefit for
MSC administration (see conclusions section).
The nature of regenerating intratubular cells in AKI:
differentiated, ‘progenitor’ or stem?
Further studies of nephron tubule regeneration have in-
terrogated whether the new cells are truly the progeny
of surviving epithelia that dedifferentiated, or are instead
the offspring of adult renal stem cells that reside within
nephrons (Figure 4B). Adult stem cells are typically rare
and possess features that unequivocally distinguish them
from their differentiated descendents—usually, a com-
bination of discrete morphological and molecular traits.
Historically, the existence of tubular stem cells was
greeted with considerable skepticism due to the lack of
any histological or expression data that suggested neph-
rons had unique subsets of cells among the differenti-
ated epithelial populace. The existence of tubular stem
cells has been revisited in recent studies. Researchers
have reexamined the morphological features of tubule
cells, reassessed the origins of tubular cells after damage,
and interrogated whether subsets of tubule cells expressed
genes that mark adult stem cells in other tissues.
Conflicting information about the proliferation capaci-
ties of tubular cells in animal models has been collected
with label retention and lineage tracing experiments.
Through long pulse-chase experiments, rare tubular
LRCs were seen in cortical nephrons of 2-month old rat
kidneys when BrdU was administered just three days
after birth—suggesting that healthy tubules contain cells
that divide infrequently [66]. Others have captured a
quite different proliferation dynamic following injury.
When sequential pulses of two different DNA analogs
were administered after IRI in mice, epithelial cells in
damaged nephrons showed co-labeling frequencies con-
sistent with stochastic division of many tubular cells
[67]. Since high numbers of tubular cells were not co-
labeled, the authors concluded that the repair was un-
likely to involve a tubular stem cell [67]. However, it is
possible that this conclusion is difficult to extrapolate
because the timing parameters of this double pulse-
chase did not rule out the possibility that a subset of
intratubular cells proliferated quite rapidly just after
injury. Indeed, another research group reported a spe-
cific subset of proximal tubule cells in mice thatexpressed nuclear factor of activated T-cells cytoplasmic
1 (NFATc1) and proliferated extensively following epi-
thelial injury from mercuric chloride exposure [68]. The
discovery of the NFATc1+ proliferative tubule popula-
tion is consistent with the notion that nephrons contain
a particular subset of cells that divide after injury.
A recent body of evidence suggests human nephrons
contain rare proliferative cells with stem cell features
(Table 1) [69-73]. Stem cells express unique antigens
and can be identified with antibodies that detect these
markers. Cell surface antigens used for isolating renal
stem cells are mostly based on known markers for other
adult stem cells, and further studies are still needed to
elucidate whether other markers could be used to iden-
tify renal stem cells correctly and efficiently [69-73]. The
use of antigen strategies have led several groups to iso-
late tubule cells that exhibit impressive proliferation cap-
acities in vitro and when administered to mice with AKI,
which they termed ‘renal tubular progenitors’ [69-73].
Renal tubule progenitors were first reported based on
a study that isolated tubule cells expressing the antigen
CD133 (a marker of hematopoietic stem cells) and Pax2
from human renal cortex samples [69]. The CD133+
Pax2+ cells self-renewed and differentiated into tubule-
like structures in vitro, and incorporated into tubules
when injected into severe combined immunodeficiency
(SCID) mice with glycerol-induced tubulonecrosis [69].
Another group isolated CD133+CD24+ cells from hu-
man cortical tissue and found that this fraction could ex-
pand, differentiate into renal epithelial cells, and make
tubule-like structures in vitro [70]. The criterion of alde-
hyde dehydrogenase (ALDH) activity, which labels sev-
eral adult stem cell types, has also been used to assess
the kidney [71]. An ALDHhigh population was isolated from
proximal tubules, and shown to express CD133+CD24+
and mesenchymal markers like vimentin (VIM) [71]. A re-
cent study reported that a human CD133+CD24+CD106-
tubular progenitor population, present in both proximal
and distal segments, became the predominant regenerating
population in both acute and chronic tubular damage pa-
tients [72]. When isolated and injected intravenously into
SCID mice with rhabdomyolysis-induced AKI, human
CD133+CD24+CD106- cells engrafted into the nephrons,
generating tubular cells [72]. A panel of markers that may
give further insight into tubular progenitor fractions has
been collected, and several unique morphological traits of
CD133+CD24+VIM+ human proximal tubule cells were
also noted: namely, an absence of the brush border, re-
duced mitochondria number and reduced cytoplasm
[73]. Analogous cells were not found in healthy rat kid-
neys, but were detected after unilateral ureteral obstruc-
tion (UUO), a damage model for renal fibrosis [73].
More research is needed to reconcile between the
conflicting data concerning how nephrons are repaired:
Table 1 Characterization of renal progenitors from adult human kidneys
Origin & characteristics of
human renal progenitor
In vitro capacity In vivo renal injury model
transplantation outcome
Reference
CD133+, Pax2+ from renal cortex Self-renew, make tubular structures Engrafted into tubules of SCID mice with
glycerol-induced tubulonecrosis
[69]
CD133+, CD24+ in proximal
& distal tubules
Differentiate into renal epithelium
& make tubular structures
N.D. [70]
Aldhhigh, CD133+, CD24+ from
proximal tubule
N.D. N.D. [71]
CD133+, CD24+, CD106- in
proximal & distal tubules
High proliferative capacity; differentiate
into podocyte & tubular lineages
Engrafted into tubules of SCID mice with
rhabdomyolysis induced AKI
[72]
CD133+, CD24+, VIM+, observed
in proximal tubule
N.D. N.D. [73]
Discrete antigen combinations have isolated renal progenitors that show remarkable potency in both in vitro culture and transplantation settings as indicated.
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progenitors are the source. This controversy has not
been conclusively resolved. The evidence of renal tubule
progenitors in human kidneys is quite compelling at
present, but nevertheless remains to be substantiated in
other mammalian kidneys. Additional work is needed to
elucidate if the renal tubular progenitors are bona fide
stem cells. Stem cells are operationally defined based on
data indicating that they self-renew and make differenti-
ated progeny in vivo during tissue homeostasis and/or
injury. Lineage tracing to assess the clonogenicity of
renal progenitors is needed to track their progeny in the
kidney. Such studies will determine the most appropriate
nomenclature for these cells. A current challenge is the
need to identify specific promoters that can be used to
make the necessary transgenic strains in the murine or
other models. This will necessitate determining markers
of these cells in animal models, though attractive candi-
dates, such as NFATc1, already exist.
Further studies are also needed to delineate the rela-
tionship(s) and functional distinctions (if any) between
renal progenitors that are positive for different antigen
combinations. In addition, it will be interesting to recon-
cile whether or not these cells are poised in G1, or if this
attribute is indicative of some other tubular fraction(s).
As renal tubular progenitor subsets were found in both
the proximal and distal tubule [72], it will also be inter-
esting to determine the relationship and proliferation
abilities of these cells across different nephron segments.
Nephron tubule damage and maladaptive regeneration in
the setting of CKD
Although AKI research highlights the inherent repara-
tive ability of the nephron tubule, this attribute is unable
to counteract tubular damage in the CKD fibrotic micro-
environment. CKD includes a heterogenous spectrum of
clinical conditions. Nevertheless, CKD pathogenesis
shares the characteristic of escalating fibrosis, often initi-
ating with a primary injury (cell loss or abnormal behav-
ior) located at the glomerulus or tubule (Figure 4C).Fibrosis can proceed at the glomerulus (further discussed
in the next section) or in the tubulointerstitial space.
These lesions can propagate over many years, causing
nephron dysfunction, atrophy, and collapse, coincident
with damage to the vasculature that magnifies fibrogenesis
and propagates a vicious damage cycle [74]. However,
diabetic patients with pancreas transplants evinced ameli-
oration of glomerular and interstitial CKD lesions after
ten years [9,10]. Thus, renal scar regression was possible
when patients were normoglycemic over a long period of
time [9,10]. The mechanism(s) responsible for this remod-
eling remain unknown. Further, a recent clinical trial doc-
umented improved kidney function in ~3% of patients
with hypertensive CKD over an extended time period (up
to twelve years)—raising more questions about CKD prog-
nosis [75]. Despite these reports, the most prevalent out-
come for CKD patients is worsening renal function and
ongoing nephron loss.
The sequence of kidney fibrosis has been likened to a
wound healing process that goes terribly awry [76].
Renal cell damage is known to trigger the release of
cytokines and other signals that trigger inflammation
events from which myofibroblasts emerge. The origin of
myofibroblasts has been quite contentious. Past candi-
dates have included interstitial fibroblasts [76], tubular
cells that undergo EMT [77-79], and endothelial cells
[80,81]. Recent lineage tracing has indicated a pericyte/
perivascular fibroblast origin [82].
Whether there are disease situations where myofi-
broblasts emerge from more than one cell compartment
remains speculative. Elucidating the local cells and sig-
nals that influence myofibroblasts will be important to
appreciate the cross talk that governs the progression of
fibrosis in different settings. Understanding more about
nephron tubular regeneration may provide viable clues
as to how nephron loss can be diminished in CKD. In
fact, abnormal tubular repair after AKI is thought to be
one way to initiate CKD, and the severity of AKI is a ro-
bust predictor for the development of CKD [83]. There
is also data from animal studies showing that tubular
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mice subjected to a single round of targeted destruction
of tubular cells in the S1 and S2 proximal segments
could regenerate through extensive tubular proliferation,
but three rounds of targeted injury led to varying de-
grees of interstitial fibrosis [84]. It is unknown if this is
the case in the S3 and other tubular segments. These
findings suggest that work is needed to address how
tubular regenerative capacity changes over time, and
how it is influenced by past kidney health and the gen-
eral progression of aging. It remains puzzling why some
renal insults are robustly countered with successful re-
generation while other injuries lead to futile or actually
more damaging cellular responses. While discovering
ways to enhance diminished tubule regeneration may
provide a viable avenue to protect against nephron loss,
the amelioration of myofibroblast activity is still likely to
be a keystone for CKD treatment.
Glomerular activities of parietal epithelial (stem?) cells:
roles in growth, podocyte turnover, and maladaption in
CKD
The discovery of glomerular parietal epithelial cells with
proliferative potential
The glomerulus is comprised of at least four cell types: a
perimeter of parietal epithelial cells (PECs) that form the
extra-glomerular tuft, and a central glomerular tuft
consisting of podocytes, endothelial cells, and mesangialFigure 5 Glomerulus homeostasis and changes in disease: the activiti
located at the urinary pole are proposed to produce podocyte precursors t
podocytes lost during normal nephron function. The link between PECs an
evidence suggests that PECs may be multipotent, with the ability to gener
typified by hallmark lesions in which progressive scar formation is caused b
Bowman’s space that can include the denuding of the glomerular baseme
lesion is depicted. The pathogenesis of glomerular disease is thought to em
PEC proliferation.cells (Figure 5A). Recent studies have suggested that
some PECs produce podocytes and exhibit stem cell fea-
tures in several contexts [85-88]. Distinct subsets of
PECs were first reported based on differential expression
of CD24 and CD133 in human kidneys [85]. PECs ex-
pressing CD24+ and CD133+ were found in close prox-
imity to the urinary pole, which is the junction between
the glomerulus and tubule [85]. When isolated and
grown in culture, CD24+CD133+ PECs exhibited high
colony-forming capacity and self-renewal potential [85].
They could differentiate into cells that acquired markers
associated with a variety of cell types (e.g. proximal or
distal tubule cells, adipocytes, osteogenic cells or neu-
rons) when grown in appropriate conditions [85]. Fur-
ther, CD24+CD133+ PECs contributed to damaged
tubules and restored kidney function when injected into
SCID mice with rhabdomyolysis-induced AKI [85]. Next,
a CD24+CD133+ PEC population was found at the
urinary pole in developing human kidneys [86]. The em-
bryonic CD24+CD133+ PECs had similar proliferative
capacities as their adult counterparts with in vitro cul-
ture tests [86]. Interestingly, when they were tested with
an in vivo xenograft administration assay, they displayed
higher rates of tubular engraftment possibly reflecting
enhanced regenerative potential [86].
Further scrutiny of the CD24+CD133+ PEC popula-
tion based on expression of the podocyte marker
podocalyxin (PDX) suggested a hierarchy of lineagees of PEC podocyte progenitors. In the healthy kidney (A), PECs
hat migrate around Bowman’s capsule to replace differentiated
d tubular progenitors has not yet been resolved, though in vitro
ate podocytes and tubular epithelial cells. (B) Glomerular disease is
y the accumulations of cells and extracellular matrix (ECM) in the
nt membrane (GBM) via podocyte detachment. An advanced sclerotic
erge from insults to podocytes and/or the activation of abnormal
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duced cells that expressed tubule or podocyte markers,
while CD24+CD133+PDX+ PECs produced just podocytes
[87]. Further, only CD24+CD133+PDX- PECs improved
kidney function when administered to mice with
adriamycin nephropathy, engrafting into glomerular and
tubular structures [87]. Interestingly, a discrete spatial
arrangement of these cells was noted in the glomerulus,
with CD24+CD133+PDX- PECs at the urinary pole,
CD24-CD133-PDX+ podocytes at the vascular pole, and
another epithelial population situated in between that
were CD24+CD133+PDX+ [87].
The new working model of podocyte ‘stem’ cells
These findings led to the proposal of a largely compel-
ling model that PECs located at the urinary pole are in
fact podocyte stem cells that upon division produce pro-
genitors that migrate slowly around the capsule and
eventually replace lost or damaged podocytes [87]. It is
known that humans shed podocytes into the urine when
the kidney is healthy, and patients with glomerular dis-
eases excrete elevated numbers of podocytes (up to 400
fold more) [35]. Podocytes from the mouse and rat can
undergo hypertrophy in culture in response to mechan-
ical stress [88,89] and high glucose media [90], and hu-
man podocytes undergo hypertrophy in disease states
such as diabetes [91,92]. However, hypertrophy is not
thought to account for podocyte shedding in healthy
kidneys, and podocytes themselves are post-mitotic
based on pulse-chase studies [93]. Thus, the PEC stem
cell model proffers an explanation that accounts for
podocyte homeostasis over life. In support of the PEC
stem cell model, genetic lineage data from mice tracked
the ability of PECs located at the glomerular urinary pole
to differentiate into podocytes during and after post-
natal nephrogenesis [94]. These findings implicate PECs
as the means for normal glomerular growth, and are
consistent with the idea that PECs serve to maintain
podocyte numbers. Additional lineage tracing in adults
is needed to further support the model. Other studies
that isolated self-renewing cell lines from human and
mouse glomeruli reported that these cells express vari-
ous developmental genes [95,96]. Uncovering the roles
of these genes could provide useful mechanistic insights
into PEC behavior.
There is experimental evidence that abnormal PEC
proliferation after glomerular injury can lead to maladap-
tive glomerular lesions that elicit CKD [97,98] (Figure 5B).
Pathologic changes can include hyperplastic lesions like
glomerular crescents, which are accumulations of prolifer-
ating cells in the extracapillary space [97]. Over time,
crescents can obstruct glomerular outflow to the tubule,
leading to tubule degeneration and consequent nephron
destruction. In addition, lineage tracing has shown thatactivated PECs can participate in sclerotic lesions in which
cells invade the capsule and deposit extracellular matrix
leading to progressive glomerular scarring [98], which
destroys the glomerulus and causes proteinuria that ul-
timately damages the nephron. Further work to discover
the signals leading to abnormal PEC proliferation will
be crucial for understanding and obviating maladaptive
PEC behavior. Toward this end, some factors that influ-
ence PEC cell fate decisions during development have
been identified, such as Wnt and BMP [99], and the
modulation of the Notch pathway has been implicated
in balancing glomerular cell proliferation and regener-
ation after injury [100].
The precedence that glomerular lesions can regress
comes from biopsy analysis of diabetic patients who re-
ceived pancreas transplants [9,10]. Clinical studies have
shown that administration of angiotensin-converting
-enzyme (ACE) inhibitor reversed proteinuria and CKD
progression in patients with non-diabetic chronic
nephropathy [101,102] and in diabetics [103]. The
mechanism for how ACE inhibition treatment triggers
regression in humans is hard to address due to the diffi-
culty in obtaining repeat biopsies. However, work in ani-
mal models showed that ACE inhibition correlated with
structural changes in the glomerulus including podocyte
repopulation [104] and reduced proliferation in sclerotic
lesions [105]. These findings provide hope that it may
be feasible to reverse, halt, or slow glomerular scarring.
In turn, lessened or obviated glomerular scarring may
prevent nephron atrophy.
The renal papilla as a putative site for renal stem cells
The renal papilla, or inner medulla, is a central region of
the adult kidney that contains epithelial tracks of collecting
ducts and nephron tubule intermediate segments (the
loops of Henle) that concentrate urine (Figure 2). Whether
the papilla serves as a niche for renal stem cells has been
highly controversial. Evidence that the papilla may harbor
renal stem cells originated from BrdU pulse-chase experi-
ments: LRCs were found in papilla tubules and interstitial
cells, and their number was reduced following ischemia,
leading to the hypothesis that the LRCs might be involved
in renal repair [66]. Plasticity of the papilla cells was tested
in vitro, where some papilla cells proliferated to form
spherical cell aggregates that co-expressed epithelial and
mesenchymal markers [66]. The proliferation and migra-
tion of LRCs was also observed during normal homeosta-
sis, and their number decreased with age, suggesting they
may represent a renal stem cell pool responding to IRI
[106]. Conflicting labeling results were also reported—
namely that the papilla LRCs became quiescent early dur-
ing renal organogenesis [107].
Meanwhile, the renal papilla was proposed to be a
stem cell niche when marker-based approaches were
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in brain and mesonephric mesenchyme [108]. By exam-
ining Nestin-GFP expression in transgenic mice, a large
number of Nestin-expressing cells were detected as
clusters in the renal papilla [108]. Nestin expression has
been correlated with CD133, and Nestin+CD133+ cells
were found extensively in the renal papilla [109]. The
plasticity of these cells was tested through in vitro cul-
ture assays, where the cells showed the capacity for
tubulogenesis [109].
Despite this body of evidence, not all approaches have
supported the notion that the papillary region harbors
renal stem cells that migrate to injured regions of the
kidney. For example, the migration and proliferation of
papillary LRCs after renal IRI was refuted by other BrdU
pulse-chase experiments that failed to observe similar
events [67]. In another report, the expression of telomer-
ase reverse transcriptase (mTert) expression was sur-
veyed after kidney injury because this gene marks
embryonic and adult stem cells [110]. Expression of
mTert could be detected in a subset of papillary epithe-
lial cells, but this population neither divided nor mi-
grated out of the renal papilla during repairing phases,
suggesting they were not a progenitor-cell population
[110]. While the existence of stem cells in the papilla re-
mains an area of research filled with contradictory re-
ports, it is reasonable to speculate that there must be
some molecular mechanism(s) to support cell turnover
and damage in this kidney region.
The problem of resolving disparate reports of putative
renal stem cell populations
Many laboratories have reported finding kidney cells
with stem cell characteristics that may correspond to
one, several or even none of the cell types already
discussed. Therefore, a significant and unresolved issue
is whether the cells described by different researchers
are distinct or identical to each other. In the following
subsections we provide a short discussion of the infor-
mation gathered about various putative renal stem cells
based on gene expression data and/or assays of prolifera-
tive potential.
The establishment of renal stem cell lines from adult
kidneys
In vitro studies have been performed with LRCs isolated
from adult ischemic rat kidneys after BrdU labeling, by
virtue of their low Hoechst staining in the presence of
BrdU [39]. In this damage context, LRCs are enriched in
proximal tubules. The Hoechstlow/BrdU+ LRCs prolifer-
ated in culture, forming tubule-like structures in condi-
tions that enabled tubulogenesis, and incorporating into
nephrons and interstitium when cultured with develop-
ing rat metanephric kidneys [39]. After isolating singlecells from a healthy rat nephron, another group
established a cell line that could expand greatly in cul-
ture and generate differentiated tubule cells in different
culture conditions; this cell line could also engraft into
rat kidney tubules after IRI [111]. However, due to the
complex cellular composition of the nephron, the origin
of this cell line is unclear. Another caveat in interpreting
both of these studies is that the cells of origin are likely
from the nephron, but could nonetheless be from other
locales as well, such as the interstitium.
A multipotent population of nontubular cells was iso-
lated from the mouse kidney based on the expression of
stem cell antigen-1 (Sca-1) and the absence of lineage
(Lin) markers of bone-marrow-derived stem cells [112].
Global gene expression analysis found enriched expres-
sion of mesodermal lineage genes, and that the Sca-1+
Lin- population could potentially contribute to renal re-
pair after IRI [112]. Multipotent renal progenitor cells
(MRPCs) isolated by culturing rat kidney cells showed
high self-renewal capacity and expression of genes in-
volved in kidney development, like Pax2 [113]. MRPC
potency was demonstrated in vitro, as the cells were able
to differentiate into myogenic, adipogenic, neural or
osteogenic lineages; further, MRPCs differentiated into
renal tubular cells after they were injected into the par-
enchyma of damaged murine kidneys [113]. Another
group isolated what they termed mouse kidney progeni-
tor cells (MKPC) from the interstitium of the medulla
and papilla that exhibited self-renewal capacity and
expressed early nephrogenesis genes [114]. Injection of
MKPC rescued renal damage when administered to IRI
damaged murine kidneys, and incorporation of MKPCs
into some renal tubules was observed [114].
Interestingly, MSCs have been cultured from the renal
capsule, which is a thin sheet of connective tissue that
envelops the kidney and contains fibroblasts, adipocytes,
and blood vessels [115]. After IRI, capsule cells migrated
into the renal parenchyma, where they are postulated to
participate in the injury response [115]. There have been
other reports of MSCs found in adult kidneys, such as
the isolation of MSCs able to differentiate into endo-
thelial and smooth muscle cells that could promote
vasculogenesis in IRI [116,117]. A limitation in
interpreting all of these renal stem cell line studies is
that culture conditions can have a significant impact on
cellular behaviors that makes understanding the identity
and potency of the cells somewhat convoluted in the ab-
sence of data to irrefutably track them in vivo during
health or injury.
Kidney side population studies
Stem cells can be isolated through flow cytometry due
to their ability to efflux Hoechst 33342 dye and are char-
acterized as a so-called side population (SP). Several SP
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heart, lung, and skeletal muscle. Kidney SP cells from
the mouse [118,119] and rat [120] have been character-
ized, and expression of particular genes like Musculin/
MyoR has been annotated [119]. Another group isolated
a renal SP population located in the proximal tubule,
supporting a ‘tubular niche’ hypothesis [121]. These SP
cells were highly heterogeneous, although they showed a
humoral role during renal repair without tubular inte-
gration [121]. The existence of SP cells in adult human
kidneys has also been reported [122,123]. However,
in vitro characterization demonstrated the heterogeneity
of human renal SP population as well, indicating SP cells
cannot be equally considered as stem cells [122]. The
ability of SP cells to improve renal regeneration has been
reported, and the mechanism behind this ameliorative
role may be due to their generation of bone morpho-
genic protein 7 (BMP7), which reversed chronic renal
injury when given exogenously and could be induced by
treatment with a histone deacetylase inhibitor [124].
Taken together, whether kidney SP cells represent a par-
ticular stem cell population still remains controversial
because renal SP cells show considerable heterogeneity.
To date, the SP assay has not served to unequivocally
identify kidney stem cells, and future work is needed to
assess if podocyte or tubular progenitors exhibit the SP
phenotype, or can be enriched using this parameter.
Prospects for future research
It is clear that there are many gaps in our understanding
about tubular, glomerular, and other speculated stem cell
fractions in the kidney. However, there are several prom-
ising research venues that may provide novel insights
into how regenerative kidney cells work. One such area
is the study of renal development. Developmental
studies are applicable for understanding regeneration
because information about how kidney lineages are
formed can provide gene expression data that could
help pinpoint adult renal stem cells and the signaling
pathways that modulate the mobilization and behavior
of reparative cells. Further, knowledge from studying
embryonic progenitors during kidney development may
be directly relevant to adult cell types, as multipotent
renal progenitors isolated from adult kidneys could rep-
resent a subset of embryonic progenitors that persist
from early nephrogenesis.
Another promising topic concerns how kidney cells
sense injury and interact with their environment. Under-
standing how kidney cells perceive and react to local
damage may provide critical information about the early
events in kidney disease. A fundamental player is likely
to be the primary cilium [125]. Cilia are organelles that
play crucial roles in how cells interact with their envir-
onment. Two types of cilia have been documented invertebrates, motile cilia and the non-motile primary
cilium [126]. Primary cilia are chemical and mecha-
nosensors between the cell and its milieu [126]. In
healthy adult human kidneys, the epithelial cells lining
the lumen of nephrons and collecting ducts have pri-
mary cilia with a 9+0 microtubule structure that interact
with urinary flow [127]. Cilia defects cause cystic kidney
diseases, characterized by abnormalities in nephron
tubular epithelial cells that lead to their overproliferation
and development of fluid-filled cysts. Since changes in
urinary flow during AKI and CKD are likely sensed by
tubule residents through the primary cilium, this signal
transduction may have important ramifications for how
tubular cells recognize injury. Thus, primary cilium sig-
naling may hold a prominent position in the course of
events that lead to nephron regeneration or maladaptive
responses.
Conclusions
New therapeutic options are needed to mitigate kidney
disease. The intricate cellular composition of the kidney
poses challenges both to understanding and treating kid-
ney disease. The presence of many renal cell types likely
means that the microenvironments in the kidney are
manifold and diverse. Nevertheless, the discovery of re-
generative renal cells in adult kidneys—especially those
in the nephron tubule and PECs in the glomerulus—pro-
vides hope that there are already cell templates and con-
ducive environs where kidney integrity can be restored
by promoting regenerative mechanisms. Improvements
in the detection of specific kidney diseases with diagnos-
tic biomarkers that can reliably predict tissue alterations
are crucial in the years ahead. Emerging evidence sup-
ports the notion that renal progenitors are a conserved
evolutionary phenomenon, and novel future insights are
likely to be gleaned from the analysis of renal progeni-
tors across the animal kingdom [128].
One important element of creating regenerative thera-
peutics will involve the discovery of how to deliver and
control such interventions in time and space, as cau-
tioned by the ability of unchecked PEC proliferation to
initiate glomerular lesions. Phenotypic improvements
triggered by alterations in the microenvironment, as ex-
emplified by the paracrine effects of MSCs when they
lodge in renal parenchyma, may be a viable place to
start. Many clinical trials with stem cell therapies are
currently underway, both with MSCs and other cell
types [129]. There have been encouraging outcomes with
the safety of using autologous transplants, which pro-
vides preliminary reassurance that the efficacy of admin-
istering mobilized MSCs (or other cells) to ameliorate
human kidney disease may be testable in the near future.
Further, in experimental models of CKD, various studies
have shown that BMP7 can inhibit or even reverse
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BMP7 pathway may provide one avenue to help patients
with CKD [130].
Considerations of the appropriate target patient popu-
lation will also need to weigh more than the kidney
disease diagnosis: variables like age and the burden of
co-mordibities will also be factors that come into play.
Like other body organs, the aging kidney shows dramatic
alterations [131]. For example, it has been appreciated
for decades that proliferative capacity of the mammalian
kidney declines with age [132]. However, recent experi-
mental studies have documented that young bone mar-
row cells from mice could alleviate aspects of renal
aging when administered to old mice [133]. This sug-
gests that therapeutic options may be enhanced as pa-
rameters like cellular age are considered and explored.
Taken together, recent research has uncovered enticing
data that several cell types within the kidney have innate
regenerative capacity. It will be essential to understand
how to enhance or induce regeneration in a controlled
fashion that can prevent maladaptive outcomes arising
from perturbed cell behavior. Although this may turn
out to be a complicated line to walk, the existence of
several stem cells in the kidney provides encouragement
that regenerative approaches might be harnessed to
combat renal disease in the not-so-distant future.
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